recent
caus
global
health
crisi
effect
intervent
therapi
urgent
need
rnadepend
rna
polymeras
rdrp
provid
promis
challeng
drug
target
due
intrins
proofread
exoribonucleas
exon
function
nucleosid
triphosph
ntp
analogu
ad
grow
rna
chain
supposedli
termin
viral
rna
replic
exon
cleav
incorpor
compound
counteract
efficaci
remdesivir
target
rdrp
exert
high
drug
efficaci
vitro
vivo
howev
underli
inhibitori
mechan
remain
elus
perform
allatom
molecular
dynam
md
simul
accumul
simul
time
microsecond
elucid
molecular
mechan
underli
inhibitori
effect
remdesivir
nucleotid
addit
rdrp
complex
proofread
exon
complex
found
group
remdesivir
possess
dual
role
inhibit
nucleotid
addit
proofread
nucleotid
addit
show
incorpor
one
remdesivir
suffici
termin
rna
synthesi
instead
presenc
polar
group
remdesivir
upstream
site
caus
instabl
via
electrostat
interact
salt
bridg
form
render
transloc
unfavour
may
eventu
lead
delay
chain
termin
rna
extens
three
nucleotid
proofread
remdesivir
inhibit
cleavag
via
steric
clash
group
examin
role
group
remdesivir
inhibitori
effect
studi
three
addit
ntp
analogu
type
modif
favipiravir
vidarabin
fludarabin
simul
suggest
three
prone
exon
cleavag
comput
find
support
vitro
assay
vero
cell
use
live
doserespons
curv
suggest
among
test
ntp
analogu
remdesivir
exert
signific
inhibitori
effect
viral
replic
work
provid
plausibl
mechan
molecular
level
remdesivir
inhibit
viral
rna
replic
find
may
guid
ration
design
new
treatment
target
viral
replic
novel
coronaviru
coronaviru
cov
sever
acut
respiratori
syndrom
coronaviru
spread
rapidli
caus
seriou
outbreak
eventu
pandem
around
world
april
report
countri
almost
million
case
confirm
result
death
estim
mortal
risk
new
cov
declar
global
emerg
world
health
organ
outbreak
continu
spread
global
clinic
approv
intervent
therapi
current
avail
curb
health
crisi
antivir
agent
urgent
need
treat
patient
could
take
year
develop
new
intervent
includ
therapeut
antibodi
cytokin
nucleic
acidbas
therapi
vaccin
henc
repurpos
clinic
approv
investig
drug
diseas
provid
promis
approach
develop
treatment
cov
capsid
envelop
singlestrand
rna
genom
three
structur
surfac
protein
shown
associ
capsid
viral
membran
envelop
spike
protein
sarscov
share
nucleotid
ident
chemic
compound
monoclon
antibodi
target
sarscov
surfac
protein
interrupt
bind
host
viral
receptor
investig
treat
addit
new
vaccin
target
viral
surfac
antigen
intens
develop
prevent
unfortun
drug
vaccin
inhibitori
mechan
target
surfac
receptor
may
effect
due
constant
evolut
surfac
receptor
acquir
drug
resist
evad
host
immun
respons
contrast
viral
rnadependentrna
polymeras
rdrp
protein
deepli
buri
insid
viral
capsul
function
conserv
viral
replic
render
resist
propag
drugresist
viru
thu
rdrp
serv
promis
drug
target
viru
infect
inde
inhibitor
target
polymeras
current
late
stage
clinic
trial
compar
viral
rdrp
influenza
viru
rhinoviru
rdrp
challeng
drug
develop
due
intrins
proofread
exoribonucleas
exon
function
nonstructur
protein
nsp
along
cofactor
involv
nascent
rna
prime
nucleotid
addit
ntp
analogu
inhibit
nucleotid
addit
supposedli
inhibit
rna
replic
howev
exon
shown
play
pivot
role
proofread
counteract
efficaci
ntp
analogu
excis
incorpor
ntp
analogu
exampl
ntp
analogu
ribavirin
incorpor
nascent
rna
inhibit
nucleotid
addit
sarscov
rdrp
howev
ribavirin
readili
excis
nascent
rna
may
explain
limit
efficaci
vivo
remdesivir
promis
drug
candid
treat
infect
shown
effect
compassionateus
basi
patient
hospitalis
includ
suffer
pneumonia
subsequ
clinic
trial
use
remdesivir
treat
conduct
remdesivir
shown
potent
inhibitor
cov
replic
includ
merscov
sarscov
circul
human
cov
even
though
remdesivir
ntp
analogu
incorpor
rdrp
exert
superior
antivir
activ
ntp
analogu
rate
incorpor
remdesivir
nascent
rna
higher
cleavag
exon
recent
enorm
amount
effort
place
understand
molecular
basi
remdesivir
inhibitori
mechan
rna
synthesi
due
high
sequenc
similar
sar
sarscov
serv
reliabl
model
studi
mechan
rna
replic
furthermor
cryoem
structur
recent
solv
catalyt
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
domain
show
high
structur
similar
sarscov
howev
one
sarscov
polymeras
structur
contain
nascent
templat
strand
pretransloc
state
pyrophosph
ion
ppi
still
bound
activ
site
henc
molecular
mechan
particularli
dynam
nucleotid
addit
cycl
either
ntp
ntp
analogu
remain
larg
unknown
biochem
assay
shown
mer
cov
recent
remedivir
caus
delay
chain
termin
rna
synthesi
wherein
sever
round
nucleotid
addit
still
proceed
remdesivir
incorpor
prior
complet
termin
howev
molecular
mechan
underli
delay
termin
induc
remdesivir
remain
larg
elus
furthermor
also
clear
remdesivir
evad
proofread
activ
prevent
cleav
exon
elucid
mechan
remdesivir
inhibit
rdrp
exon
conduct
aggreg
allatom
molecular
dynam
md
simul
complex
rdrp
md
simul
show
remdesivir
reduc
effici
nucleotid
addit
interestingli
found
remdesivir
upstream
site
site
block
transloc
via
interact
form
group
thu
result
delay
chain
termin
exon
found
rel
bulki
group
ribos
remdesivir
introduc
steric
interact
effect
disrupt
stabil
catalyt
activ
conform
thu
effect
inhibit
exonucleas
activ
exon
furthermor
md
simul
three
addit
ntp
analogu
contain
base
ribos
modif
favipiravir
vidarabin
fludarabin
suggest
prone
cleav
exon
underlin
import
role
substitut
remdesivir
simul
result
support
vitro
assay
examin
effici
ntp
analogu
inhibit
live
viru
growth
found
remdesivir
show
inhibitori
effect
consist
md
simul
remdesivir
reduc
effici
nucleotid
addit
rdrp
structur
model
rdrp
construct
base
cryoem
structur
sarscov
rdrp
pdbid
see
fig
templat
nascent
rna
strand
construct
structur
align
model
rdrp
noroviru
rdrp
pdbid
see
method
si
section
detail
twenti
replica
md
simul
perform
rdrp
posttransloc
state
activ
site
site
occupi
adenosin
triphosph
atp
fig
see
si
section
detail
valid
model
name
wildtyperna
first
examin
stabil
activ
site
assess
distanc
phosphat
pa
atp
atom
nucleotid
fig
typic
distanc
requir
allow
effici
catalysi
form
phosphodiest
bond
eg
structur
noroviru
rdrp
suggest
previou
comput
studi
consist
distanc
requir
found
distribut
distanc
peak
see
gray
curv
fig
furthermor
basetobas
distanc
atp
basepair
templat
nucleotid
also
measur
estim
basepair
stabil
found
basetobas
distanc
popul
similar
distanc
observ
structur
viral
polymeras
fig
addit
investig
base
stack
stabil
anoth
criteria
propens
nucleotid
addit
found
distanc
base
ntp
base
nucleotid
popul
fig
consist
distanc
observ
noroviru
polioviru
rdrp
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
addit
assess
activ
site
stabil
valid
structur
model
three
recent
solv
cryoem
structur
rdrp
see
fig
si
section
detail
two
apo
structur
rootmeansquaredevi
rmsd
ca
atom
use
comparison
model
found
averag
rmsd
pdbid
pdbid
indic
overal
architectur
model
similar
apo
cryoem
structur
holo
structur
rmsd
ca
atom
nucleotid
structur
model
holo
cryoem
structur
pdbid
respect
valid
wildtyperna
model
final
also
examin
interact
upstream
rna
protein
found
interact
observ
holo
cryoem
structur
well
maintain
md
simul
fig
valid
structur
model
next
perform
twenti
md
simul
remdesivirtp
replac
atp
activ
site
site
see
si
section
detail
interestingli
found
distribut
critic
distanc
remdesivirtp
system
still
larg
even
though
substanti
broader
compar
atp
fig
result
suggest
incorpor
remdesivirtp
still
allow
reduc
effici
compar
atp
furthermor
obviou
neg
effect
base
pair
base
stack
stabil
induc
remdesivirtp
site
fig
altogeth
observ
suggest
remdesivirtp
larg
maintain
catalyt
activ
conform
thu
ad
nascent
rna
chain
even
reduc
effici
therefor
remdesivir
satisfi
prerequisit
condit
act
chaintermin
inhibitor
remdesivir
ad
rna
chain
transloc
adjac
upstream
site
site
found
remdesivir
reduc
effici
addit
next
nucleotid
activ
site
case
also
perform
twenti
md
simul
remdesivir
site
examin
atp
incorpor
activ
site
see
si
section
detail
found
incom
atp
becom
less
stabl
remdesivir
site
particular
distanc
becom
larger
shift
averag
fig
moreov
base
stack
stabil
substanti
weaken
md
conform
show
larger
basetobas
distanc
wildtyperna
fig
observ
suggest
remdesivir
site
reduc
effici
next
ntp
addit
site
examin
remdesivir
upstream
posit
nascent
rna
strand
interfer
ntp
incorpor
perform
twenti
md
simul
system
remdesivir
site
see
si
section
detail
histogram
critic
distanc
ntp
incorpor
show
obviou
discrep
wildtyperna
fig
suggest
remdesivir
site
neglig
impact
nucleotid
addit
activ
site
altogeth
expect
remdesivirtp
incorpor
nascent
strand
subsequ
would
reduc
effici
addit
next
incom
ntp
howev
expect
reduct
may
suffici
complet
abolish
rna
synthesi
suggest
mechan
may
exist
remdesivir
inhibit
rdrp
function
remdesivir
propos
delay
chain
termin
rdrp
respiratori
syncyti
viru
nipah
viru
merscov
recent
biochem
experi
rdrp
also
demonstr
delay
chain
termin
remdesivirtp
physiolog
concentr
although
nucleotid
addit
may
termin
earlier
excess
amount
remdesivirtp
present
merscov
rna
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
replic
remdesivir
induc
delay
chain
termin
wherein
addit
effici
first
nucleotid
maintain
howev
nucleotid
addit
abruptli
abolish
specif
upstream
site
delay
molecular
mechan
underlin
delay
chain
termin
remain
larg
elus
elucid
mechan
delay
termin
perform
md
simul
rdrp
remdesivir
ad
nascent
rna
strand
differ
site
site
transloc
process
obtain
statist
meaning
result
perform
twenti
md
simul
system
see
si
section
detail
investig
propens
transloc
first
inspect
remdesivir
may
impact
stabil
rdrp
complex
examin
probabl
hydrogen
bond
form
remdesivir
templat
uracil
shown
fig
fig
hydrogen
bond
remdesivir
u
nearli
intact
remdesivir
site
pre
pret
posttransloc
postt
state
suggest
transloc
remdesivir
allow
system
worth
mention
interact
remdesivir
site
surround
residu
model
consist
recent
solv
rdrp
holo
structur
fig
observ
also
consist
recent
structur
model
studi
suggest
remdesivir
activ
site
site
hinder
transloc
sharp
contrast
found
remdesivir
site
greatli
weaken
hydrogen
bond
probabl
base
pair
templat
uracil
fig
investig
show
presenc
highli
polar
group
remdesivir
exert
strong
electrostat
attract
kjmol
salt
bridg
form
rdrp
fig
electrostat
attract
pull
remdesivir
away
canon
conform
caus
destabil
base
pair
fig
inde
hydrogen
bond
base
pair
remdesivir
u
subsequ
disrupt
render
correspond
rdrp
complex
unstabl
fig
recent
solv
cryoem
structur
also
show
spatial
proxim
group
remdesivir
model
site
transloc
rna
polymeras
postt
state
empti
activ
site
often
compar
stabil
correspond
pret
state
subsequ
bind
ntp
greatli
stabil
postt
state
favor
forward
transloc
thu
anticip
transloc
remdesivir
site
postt
still
allow
due
stabil
ntp
bind
ntp
incorpor
unstabl
complex
remdesivir
site
may
hinder
rna
extens
next
investig
instabl
induc
remdesivir
site
affect
dynam
subsequ
transloc
site
gener
transloc
pathway
use
climber
algorithm
see
method
si
section
detail
interestingli
found
group
need
first
move
closer
neg
charg
transloc
away
site
distanc
notic
larger
transloc
fig
electronwithdraw
moieti
exhibit
anion
repuls
intermedi
conform
reduc
distanc
experi
unfavor
repuls
kjmol
rais
energi
see
fig
expect
may
hinder
forward
transloc
fig
altogeth
observ
suggest
delay
termin
three
nucleotid
observ
merscov
gordon
et
al
propos
altern
explan
steric
clash
remdesivir
would
inhibit
transloc
site
site
transloc
simul
found
group
remdesivir
constantli
approach
distanc
monoton
decreas
around
fig
howev
observ
strong
steric
clash
remdesivir
nevertheless
due
spatial
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
proxim
anticip
may
still
play
auxiliari
role
inhibit
transloc
base
homolog
model
shannon
et
al
propos
anoth
mechan
transloc
inhibit
due
steric
clash
remdesivir
ribos
site
howev
md
simul
remdesivir
site
show
larg
distanc
group
remdesivir
fig
consist
simul
larg
separ
group
remdesivir
also
observ
model
remdesivir
site
use
recent
cryoem
structur
pdbid
see
fig
obtain
transloc
pathway
adopt
climber
method
rdrp
complex
progress
driven
pret
postt
state
extern
energi
rigor
studi
dynam
largescal
conform
chang
transloc
need
appli
advanc
method
markov
state
model
beyond
scope
current
studi
final
comparison
sequenc
coronavirus
indic
salt
bridg
conserv
except
ly
replac
anoth
posit
charg
arg
two
human
cov
fig
impli
propos
mechan
may
employ
cov
rdrp
one
main
challeng
drug
design
target
rdrp
due
exist
exon
domain
bind
perform
proofread
function
remov
incorpor
ntp
analogu
counteract
efficaci
inhibitori
compound
therefor
addit
criterion
effect
inhibitor
viral
replic
abil
escap
cleavag
exon
next
examin
effici
remdesivir
cleav
exon
built
structur
model
bound
activ
base
crystal
structur
sarscov
pdbid
previou
work
suggest
three
nucleotid
base
pair
melt
activ
site
exon
model
singlestrand
rna
contain
three
nucleotid
base
structur
align
dna
polymeras
klenow
fragment
dna
polymeras
iii
e
subunit
see
method
si
section
detail
twenti
md
simul
perform
wildtyperna
occupi
adenin
see
si
section
detail
assess
stabil
cleavag
site
examin
distanc
mga
atom
second
last
nucleotid
essenti
cleavag
fig
distanc
well
maintain
simul
fig
histogram
show
one
peak
region
fig
suitabl
cleavag
mgamgb
distanc
also
critic
cleavag
calcul
show
sharp
peak
fig
distanc
permiss
cleavag
sharp
contrast
md
simul
remdesivir
show
destabil
cleavag
site
exon
coordin
mga
atom
frequent
disrupt
fig
consist
second
peak
appear
distribut
distanc
indic
remdesivir
caus
increas
popul
cleavageinhibit
configur
fig
increas
also
observ
histogram
mgamgb
distanc
second
peak
clearli
appear
fig
examin
base
step
twist
angl
fig
show
base
remdesivir
twist
significantli
adenin
fig
also
suggest
remdesivir
experienc
unfavor
interact
observ
indic
remdesivir
stabl
cleavag
site
henc
prone
cleav
structur
analysi
base
md
conform
remdesivir
indic
bulki
group
play
key
role
protect
remdesivir
exon
cleavag
cleavag
site
surfac
protein
base
nucleotid
expos
solvent
contrast
ribos
ring
buri
within
protein
environ
thu
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
suscept
instabl
incur
cleavag
site
wildtyp
nucleotid
bulki
group
attach
ribos
ring
henc
specif
steric
effect
observ
cleavag
site
shown
repres
conform
wildtyperna
fig
convers
group
remdesivir
caus
steric
clash
side
chain
protein
residu
steric
repuls
separ
remdesivir
apart
consolid
larger
distanc
base
nitrogen
atom
amid
group
fig
steric
interact
clearli
demonstr
repres
conform
shown
fig
one
hand
remdesivir
adopt
similar
conform
wildtyperna
cyano
group
push
side
chain
hand
side
chain
maintain
configur
wildtyperna
steric
interact
push
ribos
along
base
remdesivir
rotat
away
fig
therefor
attribut
destabil
remdesivir
cleavag
site
steric
repuls
group
remdesivir
observ
md
simul
consist
recent
studi
base
static
structur
model
also
propos
group
steric
clash
cleavag
site
destabil
would
reduc
possibl
remdesivir
excis
exon
enabl
remdesivir
effect
inhibitor
understand
import
chemic
featur
remdesivir
allow
inhibit
nucleotid
addit
cleavag
viral
replic
explor
inhibitori
effect
three
addit
ntp
analogu
contain
variou
chemic
structur
featur
favipiravir
vidarabin
fludarabin
three
compound
fda
approv
drug
display
hydrogen
bond
pattern
correspond
natur
adenin
nucleotid
fig
howev
structur
differ
adenin
either
base
favipiravir
ribos
vidarabin
like
remdesivir
fludarabin
modif
base
ribos
therefor
examin
ntp
analogu
provid
insight
type
modif
may
benefit
inhibitor
design
first
perform
md
simul
place
triphosph
form
ntp
analogu
activ
site
site
see
si
section
detail
evalu
ntp
analogu
could
satisfi
criteria
incorpor
nascent
strand
rdrp
potenti
chain
termin
favipiravirtp
vidarabinetp
shown
possess
similar
mean
distanc
compar
remdesivir
fig
distanc
significantli
rais
fludarabinetp
implic
difficulti
fludarabin
incorpor
nascent
rna
strand
inspect
md
conform
reveal
instabl
fludarabinetp
activ
site
could
attribut
fluorosubstitut
base
fluorin
atom
electroneg
caus
drepuls
oxygen
atom
base
templat
uracil
fig
thu
destabil
configur
activ
site
basetobas
distanc
ntp
analogu
templat
nucleotid
activ
site
margin
increas
ntp
analogu
compar
wildtyperna
fig
similarli
mean
base
stack
distanc
ntp
analogu
equal
even
shorter
atp
fig
observ
suggest
ntp
analogu
except
fludarabinetp
satisfi
structur
featur
criteria
incorpor
nascent
strand
next
examin
ntp
analogu
inhibit
nucleotid
addit
place
site
atp
activ
site
twenti
md
simul
perform
system
see
si
section
detail
favipiravir
found
averag
distanc
favipiravir
site
similar
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
remdesivir
site
fig
demonstr
favipiravir
weak
capabl
reduc
effici
next
ntp
incorpor
vidarabin
fludarabin
shown
even
shorter
distanc
wildtyperna
due
extra
hydrogen
bond
form
group
ntp
analogu
ntp
hydrogen
bond
probabl
vidarabin
fludarabin
respect
basetobas
distanc
ntp
templat
nucleotid
perturb
presenc
ntp
analogu
site
fig
favipiravir
also
show
similar
base
stack
distanc
wildtyperna
distanc
slightli
increas
around
vidarabin
fludarabin
fig
addit
none
three
ntp
analogu
contain
bulki
substitut
group
ribos
like
remdesivir
fig
anticip
unlik
inhibit
rna
synthesi
via
delay
termin
mechan
altogeth
expect
favipiravir
reduc
ntp
incorpor
similar
extent
remdesivir
vidarabin
fludarabin
reduc
ntp
incorpor
due
shorten
distanc
therefor
base
comprehens
analysi
three
ntp
analogu
perform
rdrp
favipiravir
possibl
candid
next
examin
ntp
analogu
could
inhibit
proofread
exon
place
nascent
rna
strand
see
si
section
detail
three
ntp
analogu
mgamgb
distanc
compar
adenin
implic
prone
excis
exon
fig
furthermor
three
ntp
analogu
adopt
similar
configur
adenin
cleavag
site
fig
experi
steric
clash
fig
anticip
stabil
three
compound
cleavag
site
attribut
lack
bulki
substitut
consist
propos
bulki
group
caus
steric
effect
contribut
instabl
cleavag
site
altogeth
result
suggest
three
ntp
analogu
prone
excis
remdesivir
implic
effect
inhibit
rna
replic
consolid
abovement
simul
result
perform
vitro
experi
vero
cell
show
ntp
analogu
favipiravir
vidarabin
fludarabin
inde
fail
inhibit
replic
fig
particular
perform
vitro
tissu
cultur
assay
use
live
viru
examin
antivir
effect
remdesivir
favipiravir
vidarabin
fludarabin
viru
among
four
ntp
analogu
test
remdesivir
found
inhibit
replic
vero
cell
fig
consist
previou
work
determin
vidarabin
use
viru
titer
realtim
pcr
respect
ntp
analogu
vidarabin
fludarabin
favipiravir
inhibit
viral
replic
fig
howev
worthi
note
ntp
analogu
requir
convers
triphosph
form
host
nucleosid
kinas
whose
activ
may
differ
among
cell
type
henc
evalu
effect
ntp
analogu
primari
cell
primari
human
airway
epitheli
cell
clinic
relev
need
consid
inhibit
effect
three
ntp
analogu
rdrp
exon
found
none
exhibit
superior
inhibitori
activ
remdesivir
work
elucid
molecular
mechan
lack
inhibitori
effect
rna
synthesi
fludarabin
lowest
tendenc
incorpor
nascent
strand
vidarabin
could
reduc
effici
incom
ntp
incorpor
rdrp
favipiravir
demonstr
similar
perform
remdesivir
rdrp
howev
favipiravir
highli
like
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
cleav
exon
henc
remdesivir
inhibit
rna
synthesi
rdrp
simultan
avoid
excis
exon
rdrp
studi
elucid
import
role
group
ribos
remdesivir
inhibit
effect
target
rna
replic
fig
extens
md
simul
perform
base
structur
model
rdrp
exon
remdesivir
site
reduc
nucleotid
addit
activ
site
fulli
inhibit
nucleotid
addit
instead
remdesivir
mainli
inhibit
nucleotid
addit
via
delay
chain
termin
mechan
grow
rna
chain
termin
nucleotid
ad
remdesivir
incorpor
propos
model
polar
group
remdesivir
upstream
site
caus
instabl
rdrp
complex
salt
bridg
pull
remdesivir
away
canon
conform
break
base
pair
furthermor
dynam
transit
transloc
site
site
hinder
due
unfavor
aniondrepuls
group
remdesivir
result
remdesivir
lead
delay
termin
three
nucleotid
addit
remdesivir
found
capabl
inhibit
proofread
function
exon
group
remdesivir
exhibit
steric
clash
nearbi
residu
destabil
remdesivir
activ
site
render
resist
exon
cleavag
investig
use
three
ntp
analogu
show
differ
inhibit
effect
nucleotid
addit
rdrp
albeit
prone
cleav
remdesivir
comparison
among
structur
modif
remdesivir
three
ntp
analogu
suggest
modif
ribos
possibl
use
bulki
group
substitut
may
better
strategi
base
inhibit
rna
synthesi
work
provid
mechanist
insight
atomist
detail
remdesivir
effect
inhibit
rna
synthesi
also
reveal
chemic
modif
ribos
remdesivir
carri
dual
inhibitori
function
termin
nucleotid
addit
proofread
could
promis
gener
strategi
design
prospect
nucleosideanalog
inhibitor
treat
cryoem
structur
complex
pdbid
noroviru
holordrp
pdbid
use
structur
basi
construct
ncov
rdrp
contain
dsrna
strand
atp
bound
activ
site
see
si
section
detail
proton
state
histidin
predict
use
modul
packag
follow
manual
investig
ensur
coordin
zinc
ion
form
whole
complex
place
dodecahedron
box
box
edg
least
away
complex
surfac
box
fill
water
molecul
enough
counter
ion
ad
make
whole
system
neutral
crystal
structur
complex
sarscov
pdbid
serv
structur
basi
construct
see
si
section
detail
miss
residu
model
singlestrand
rna
contain
three
nucleotid
model
structur
align
cleavag
site
proofread
exon
domain
dna
polymeras
klenow
fragment
pdbid
esubunit
dna
polymeras
iii
pdbid
due
similar
architectur
cleavag
site
proton
state
histidin
estim
modul
packag
complex
solvat
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
water
dodecahedron
box
edg
least
away
complex
surfac
suffici
counter
ion
ad
neutral
system
use
forc
field
simul
protein
nucleotid
forc
field
paramet
ntp
analogu
deriv
base
exist
forc
field
paramet
gener
amber
forc
field
see
si
section
detail
partial
charg
ntp
analogu
gener
follow
restrict
electrostat
potenti
scheme
see
si
detail
atp
ntp
analogu
triphosph
form
paramet
triphosph
tail
taken
develop
meagher
et
al
system
gradual
relax
product
simul
nvt
ensembl
k
vrescal
thermostat
appli
coupl
time
constant
ps
longrang
electrostat
interact
beyond
cutoff
treat
particlemesh
ewald
method
lennardjon
interact
smoothli
switch
neighbor
list
updat
everi
step
integr
time
step
fs
use
linc
algorithm
appli
constrain
bond
save
snapshot
everi
ps
simul
perform
gromac
equilibr
system
contain
wildtyp
rna
serv
structur
basi
model
ntp
analogu
correspond
site
investig
inhibitori
effect
detail
md
simul
si
section
transloc
pathway
remdesivir
site
use
climber
algorithm
gener
pathway
transloc
remdesivir
site
see
si
section
detail
pret
postt
conform
construct
base
pret
model
remdesivir
site
postt
model
remdesivir
site
respect
perform
climber
simul
doubl
strand
rna
gradual
driven
pret
state
postt
state
extern
energi
vitro
assay
live
viru
determin
ntp
analogu
viru
name
betacovhong
isol
nasopharynx
aspir
throat
swab
confirm
patient
hong
kong
stock
viru
prepar
passag
use
vero
cell
atcc
infect
media
dmem
supplement
gl
dglucos
mgl
sodium
pyruv
fb
ul
penicillinstreptomycin
mm
hepe
compound
medchemexpress
stock
prepar
dmso
evalu
effect
compound
vitro
vero
cell
pretreat
compound
dilut
infect
media
h
prior
inocul
viru
multipl
infect
antivir
compound
present
viru
inoculum
incub
period
inoculum
remov
vero
cell
overlaid
infect
media
contain
respect
dilut
compound
h
incub
supernat
collect
quantifi
viral
load
assay
quantit
realtim
rtpcr
fast
viru
master
mix
thermo
scientif
base
previou
protocol
logist
regress
use
fit
doserespons
curv
determin
effect
concentr
compound
inhibit
live
viral
replic
cytotoxicti
select
compound
evalu
vero
cell
use
celltiterglo
luminesc
cell
viabil
assay
promega
coronaviru
diseas
situat
report
situatioan
report
samuel
b
medic
microbiolog
univers
texa
medic
branch
galvestontx
usa
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
b
comparison
model
grey
apo
cryoem
structur
pdbid
green
c
comparison
model
grey
holo
cryoem
structur
pdbid
orang
right
panel
templat
strand
cyan
nascent
strand
red
model
compar
cryoem
structur
see
si
section
calcul
detail
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
left
panel
repres
md
conform
display
salt
bridg
attract
rdv
shown
orang
canon
conform
two
hydrogen
bond
rdv
u
pair
shown
dash
line
group
rdv
two
oxygen
atom
carboxyl
group
quaternari
amin
group
shown
sphere
right
panel
interact
energi
group
rdv
salt
bridg
group
well
group
shown
black
red
blue
respect
see
si
section
calcul
detail
c
cartoon
model
show
transloc
rdv
site
inhibit
left
panel
distanc
group
versu
rmsd
rna
pret
state
transloc
shown
right
panel
see
si
section
detail
repres
conform
along
transloc
pathway
rdv
site
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
ion
c
histogram
basepair
step
twist
angl
last
two
nucleotid
histogram
distanc
nitrogen
atom
amid
group
base
see
si
section
detail
histogram
scenario
rdv
shown
orang
black
respect
e
repres
md
conform
contain
wildtyp
rna
f
repres
md
conform
rdv
group
rdv
shown
sphere
e
f
kcenter
cluster
perform
divid
conform
ensembl
cluster
center
conform
cluster
popul
shown
see
si
section
detail
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
